Page 28 - Read Online

Page 10 of 10 Burlone et al. Hepatoma Res 2020;6:3 I http://dx.doi.org/10.20517/2394-5079.2019.37

hepatocellular carcinoma in HIV-infected patients. Oncoligst 2013;18:592-9.
52. Yang JD, Altekruse SF, Nguyen MH, Gores GJ, Roberts LR. Impact of country of birth on age at the time of diagnosis of hepatocellular
carcinoma in the United States. Cancer 2017;123:81-9.
53. Yang JD, Mohamed HA, Cvinar JL, Gores GJ, Roberts LR, et al. Diabetes mellitus heightens the risk of hepatocellular carcinoma except
in patients with hepatitis C cirrhosis. Am J Gastroenterol 2016;111:1573-80.
54. Esfeh JM, Hajifathalian K, Ansari-Gilani K. Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to
explant pathology as the gold standard. Clin Mol Hepatol 2019;26:54-9.
55. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003;39:1076-84.
56. Simmons O, Fetzer DT, Yokoo T, Marrero JA, Yopp A, et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma
surveillance in patients with cirrhosis. Aliment Pharmacol Ther 2017;45:169-77.
57. Singal A, Volk ML, Waljee A, Salgia R, Higgins P, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular
carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009;30:37-47.
58. Fangazio S, Camatta D, Tran Minh M, Ceriani E, Minisini R, et al. Treatment failure after interferon-free treatment of hepatitis C as a
clue of a yet undetected hepatocellular carcinoma. J Hepatol 2017.
59. Yen YH, Chen CH, Hung CH, Wang JH, Lu SN, et al. Active hepatocellular carcinoma is an independent risk factor of direct-acting
antiviral treatment failure: a retrospective study with prospectively collected data. PLoS One 2019;14:e0222605.